Trials / Completed
CompletedNCT00288613
FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 501 (actual)
- Sponsor
- NxStage Medical · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose The purpose of this study is to compare the economical impact and clinical parameters of short daily hemodialysis using the NxStage® System One hemodialysis device with thrice-weekly conventional in-center dialysis using a matched cohort from the US Renal Data System (USRDS) database.
Detailed description
In the 21st century, nephrologists in the United States face many challenges including a forecast of decline in physician manpower. Challenges that are specific to hemodialysis (HD) include reimbursement constraints, a growing shortage of nurses and major technological advances in dialysis equipment. There is a growing interest in alternative dialysis regimen and frequency, but a lack of patient incentive for self-care dialysis either in the center or in the home setting. The proposed phase 4 post-marketing study plans to explore whether daily HD is economically attractive compared with thrice weekly HD, while improving health-related quality of life and other dialysis adequacy measures. This project is unique as it provides a large prospective cohort of patients converted to daily HD, with a longitudinal follow up and an ability to compare to a matched cohort from the United States Renal Data Services. This study will help develop whether daily dialysis is economically attractive through the use of new technologies that reduce treatment costs and decrease hospitalization rates, with the long-term hope of increasing life expectancy. All patients will have the option to participate in the Quotidian Dialysis Registry, coordinated by the Lawson Health Research Institute (LHRI) in London, Ontario.
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2006-02-08
- Last updated
- 2014-07-24
Locations
41 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00288613. Inclusion in this directory is not an endorsement.